United States Digital Pills for Mental Health Market is to reach USD 420.1 million by 2031 - Driven by Increasing Use of AI, Sensors, and Remote Monitoring in Mental Healthcare | DataM Intelligence

Leander, Texas and TOKYO, Japan- The U.S. Digital Pills for Mental Health Market was valued at approximately USD 273.5 million in 2023. It is projected to grow to around USD 420.1 million by 2031, with a compound annual growth rate (CAGR) of about 5.6% during the forecast period from 2024 to 2031.

This growth is driven by increasing adoption of digital health technologies, strategic industry developments, and regulatory advancements.

Download Free sample report:-https://www.datamintelligence.com/download-sample/digital-pills-for-mental-health-market?pratik

Industry Latest News 2025:

✅ The FDA's Digital Health Advisory Committee (DHAC) is set to meet on November 6, 2025, to evaluate AI-enabled mental health devices ( chatbots, virtual therapists).

✅ Results from the CONVOKE Phase 3 trial of CT-155, a prescription digital therapeutic (PDT) for negative symptoms of schizophrenia (developed by Click Therapeutics + Boehringer Ingelheim), showed statistically significant improvement in negative symptoms.

✅ Medscape reported that this digital therapeutic (CT-155) could be a "breakthrough" in schizophrenia care, working alongside standard antipsychotic treatment.

✅ The FDA released a document (Nov 2024, published recently) reviewing the safety/regulation of "Enabled Digital Mental Health Medical Devices," highlighting increased scrutiny on how software and sensors integrate with medication.

✅ The rising role of prescription digital therapeutics (PDTs) for schizophrenia, noting that regulatory approval requires rigorous efficacy/safety validation.

Recent Mergers & Acquisitions

- Carlyle Group acquired Psychiatric Medical Care for $400 million in a private equity-backed deal (Q3 2025).

- Cerebral, a telehealth provider, acquired Resilience Lab to expand digital mental health services.

- Uwill acquired tbh, a support platform for students and young adults addressing mental health challenges.

- Nystrom & Associates acquired the Minnesota-based operations of Ellie Mental Health, expanding locations across five states.

- Teladoc Health acquired virtual mental health provider UpLift for $30 million cash plus earnouts, enhancing therapy and medication management services.

- Lyra Health acquired Bend Health, adding pediatric mental health expertise and virtual outpatient care expansion.

- Oceans Healthcare acquired Haven Behavioral Healthcare, integrating comprehensive mental health services.

- Pax Health acquired Harris Psychiatric Services, targeting recovery outcomes in specialized mental health care.

- Rosecrance Behavioral Health acquired Ascend CHC to add specialty services including eating disorder care.

Market Segmentation Analysis

By Product Type:

- Digital Pills with Embedded Sensors: These pills have sensors embedded to monitor ingestion and adherence, critical for managing chronic conditions and mental health treatments.

- Digital Pills Ingestible Sensors: These include ingestible sensors that track medication intake and send data to healthcare providers.

- Others: Other related digital pill technologies not falling into the above categories.

By Application:

- Depression: Digital pills support medication adherence and management for depression patients.

- Anxiety Disorders: Used to help track treatment effectiveness and ensure compliance.

- Schizophrenia: A fast-growing segment with high adoption for critical adherence monitoring.

- Bipolar Disorder: Another rapidly growing application focusing on precise medication tracking.

- Others: Includes other mental health disorders benefiting from digital pill technology.

By End User:

- Healthcare Providers: Hospitals, clinics, and mental health professionals use digital pills to improve treatment outcomes.

- Pharmaceutical Companies: Use digital pills for medication tracking and patient adherence data.

- Others: Including payers, research institutions, and patients themselves.

"Secure your 30% year-end discount - get this report before the offer expires."
:https://www.datamintelligence.com/buy-now-page?report=digital-pills-for-mental-health-market?pratik ((Purchase 2 or more Repots and get 50% Discount)

The digital pills for mental health market report would provide approximately

53 tables,
47 figures,
176 pages.

Growth Drivers:-

- Rising incidence of mental health disorders like schizophrenia and bipolar disorder is fueling demand.

- Increasing awareness and diagnosis of mental health conditions push adoption.

- Digital pills improve medication adherence, enhancing treatment outcomes.

- Growth in telehealth and remote patient monitoring expands market reach.

- Advances in AI, machine learning, and wearable tech support real-time personalized care.

- Convenient access through smartphones and digital platforms increases patient engagement.

Regional Insights:-

United States:

- Market valued at approximately USD 273.5 million in 2023, expected to reach USD 420.1 million by 2031.

- Growth driven by FDA digital health initiatives and increasing adoption of AI-enabled mental health devices.

- Strong presence of key players like Otsuka America Pharmaceutical.

- Increasing telehealth integration and reimbursement policies boost market demand.

Japan:

- Rapid adoption of AI-powered digital therapeutics to improve workplace mental health.

- Focus on enhancing employee well-being and productivity through digital mental health solutions.

- Growing corporate interest drives market expansion.

- Increasing investments in digital health innovations for mental health care.

Latest Technology innovation

1. Next-generation ingestible sensors
Smaller, biocompatible, battery-free sensors that activate on stomach fluids and provide more accurate ingestion data.

2. Multi-parameter smart pills
Sensors that go beyond ingestion and monitor pH, temperature, motility, or physiological markers linked to psychiatric conditions.

3. AI-driven adherence analytics
Machine-learning models that predict nonadherence risk, relapse risk, and behavioral changes from ingestion patterns.

4. Integration with digital therapeutics (DTx)
Digital pills paired with therapy apps (CBT, mood tracking, symptom check-ins) for combined clinical monitoring.

5. Secure cloud platforms with real-time dashboards
Clinician dashboards using HL7/FHIR standards for EHR integration and remote psychiatric monitoring.

6. Patch-free ingestion detection systems
Next-gen systems eliminating the need for a wearable patch, using radio-frequency or micro-bioelectrical signals instead.

7. Blockchain-based adherence tracking
Tamper-proof adherence records for clinical trials and reimbursement validation.

Get Customization in the report as per your requirements:https://www.datamintelligence.com/customize/digital-pills-for-mental-health-market?pratik

Key Players:

Otsuka America Pharmaceutical, Inc., and Idorsia Pharmaceuticals Ltd.

Key Highlights

Otsuka America Pharmaceutical, Inc.:

- Holds a major share of the U.S. digital pills market, contributing significantly to the projected $420.1 million market by 2031.

- Consistently innovates in digital therapeutics integrating AI and personalized medicine.

Idorsia Pharmaceuticals Ltd.:

- Focuses on novel drug delivery systems coupled with digital tracking to enhance mental health treatment adherence.

- Smaller but growing player with increasing investments in digital mental health solutions.

Request for 2 Days FREE Trial Access:

https://www.datamintelligence.com/reports-subscription?pratik

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About DataM Intelligence

DataM Intelligence is a renowned provider of market research, delivering deep insightsthrough pricing analysis, market share breakdowns, and competitive intelligence. Thecompany specializes in strategic reports that guide businesses in high-growth sectors suchas nutraceuticals and AI-driven health innovations.

To find out more, visit https://www.datamintelligence.com/ or follow us on Twitter,LinkedIn and Facebook.

This release was published on openPR.